Navigation Links
Cardium Announces InnerCool's New RapidBlue(TM) System Obtains CE Mark for Commercial Sale in Europe and UL certification
Date:7/14/2008

07 Annual Report at http://www.cardiumthx.com/flash/pdf/CardiumAR07_Book_FINAL.pdf.

Cardium's InnerCool Therapies subsidiary is a San Diego-based medical technology company in the emerging field of patient temperature modulation therapy to rapidly and controllably cool the body in order to reduce cell death and damage following acute ischemic events such as cardiac arrest or stroke, and to potentially lessen or prevent associated injuries such as adverse neurological outcomes. For more information about Cardium's InnerCool subsidiary, including InnerCool's RapidBlue(TM) and CoolBlue(TM) patient temperature modulation systems, please visit http://www.innercool.com.

Cardium's Tissue Repair Company subsidiary (TRC) is a San Diego-based biopharmaceutical company focused on the development of growth factor therapeutics for the treatment of severe chronic diabetic wounds. TRC's lead product candidate, Excellarate(TM), is a DNA-activated collagen gel for topical treatment formulated with an adenovector delivery carrier encoding human platelet-derived growth factor-BB (PDGF-BB). Excellarate is initially being developed to be administered once or twice for the potential treatment of non-healing diabetic foot ulcers. Other potential applications for TRC's Gene Activated Matrix(TM) (GAM(TM)) technology include therapeutic angiogenesis (cardiovascular ischemia, peripheral arterial disease) and orthopedic products, including hard tissue (bone) and soft tissue (ligament, tendon, cartilage) repair. For more information about Cardium's Tissue Repair Company subsidiary, please visit http://www.t-r-co.com.

Forward-Looking Statements

Except for statements of historical fact, the matters discussed in this press release are forward looking and reflect numerous assumpti
'/>"/>

SOURCE Cardium Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Cardium Announces Follow-On Direct Investment by Institutional Investor
2. Cardium Selected for Inclusion in Russell Microcap Index
3. Cardiums InnerCool Therapies Unit Announces Italian Commercialization Agreement for Portfolio of Temperature Modulation Systems
4. Cardium Launches New AWARE Clinical Study Website
5. Over and Under(R) Pericardium Covered Stent is now in use in England and Proves Great Deliverability
6. Cardium Therapeutics Announces Annual Meeting of Stockholders to be Held June 5, 2008
7. Cardium Reports on First Quarter 2008 Highlights and Financial Results
8. Richard A. Schatz, M.D. Joins Cardiums Scientific Advisory Board
9. Cardium Reports on Science Channel Series Featuring InnerCools Endovascular Cooling During Brain Surgery at Stanford University
10. Cardiums InnerCool Therapies Unit Announces European Commercialization Agreement for Portfolio of Temperature Modulation Systems
11. Cardiums Corgentin Preclinical Program Shows High Levels of Targeting to Acutely Ischemic Heart Muscle Following Intracoronary Infusion

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...LGARYandBLENHEIM,Ontario,Nov.24/PRNewswire-FirstCa...ingtheassetsofHylandSeeds,adivisionofThompsonsLimi...furtherexpandDowAgroSciences,currentseedsbusinessa...TM) in 2010 andDowAgroSciencesHerbicideTolerantT...expectedinthenearfuture. ,, "Thisacquisitionbri...
(Date:11/24/2009)....LOUIS,Nov.24/PRNewswire-FirstCall/--Sigma-Aldrich...DAQOMXconferenceonTuesday,December1stat1:45PMGMTin...iveaudiobroadcastovertheInternetavailableat http:...nclickthe"Webcast"icontoaccessthisfile. ,, Ab...nceandHighTechnologycompany.Itschemicalandbiochemi...
(Date:11/24/2009)...YKJAVIK,Iceland,November24/PRNewswire-FirstCall/--...heapprovalofallofits,"firstday"motionsbytheU.S.Ban...cyCourt").deCODElastweekfiledavoluntarypetitionfor...dewiththe,BankruptcyCourt. , Theordersissuedb...rateitsbusinessduringtheChapter11proceedings.Inpar...
(Date:11/24/2009)...NMATEO,Calif.,Nov.24/PRNewswire-FirstCall/--Neurog...ocusedondevelopingandcommercializingnovelpainmanag...esidentandChiefExecutiveOfficer,isscheduledtoprese...tobeheldDecember1-2,2009atTheNewYorkPalaceHotelinN...i,ChiefFinancialOfficer,willbeavailabletorespondto...
Breaking Biology Technology:Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3
...rogesX, Inc.,(Nasdaq: NGSX ), a biopharmaceutical... novel pain management therapies, today announced ...on Thursday, May 15, 2008, before,the market opens...egin at 9:00 a.m. ET,(6:00 a.m. PT) on May 15, 200...and Chief Executive Officer, and Stephen Ghiglieri...
...wire/ -- Sinovac Biotech Ltd. (Amex: SVA ),a lead... that Mr. Weidong,Yin, CEO, and Ms. Helen Yang, In...sent at the Brean Murray, Carret & Co. All-Cap All... a.m. Eastern Standard Time at the Waldorf,Astoria...and Ms. Vanessa Wu, Senior Financial,Manager, are ...
... (NYSE: MYL ),today announced that Mylan Pharmace...U.S. Food and Drug Administration (FDA) for its Ab...le Hydrochloride Tablets, 0.25 mg,(base), 0.5 mg (... (base),and 5 mg (base)., Ropinirole Hydrochlorid...ne,s Requip(R) Tablets, which had total U.S. sales...
Other Biology Technology:NeurogesX to Report First Quarter 2008 Financial Results 2NeurogesX to Report First Quarter 2008 Financial Results 3Sinovac to Present at the Brean Murray, Carret & Co. All-Cap All-China Conference and the Roth China Discovery Tour 2008 2
(Date:11/24/2009)..., Scientists have crystallised a protein that may...act. The protein could be used by probiotic produc...eal benefit to people. , "Probiotics need to inte...l effect, and if they attach to surfaces in the gu... to exert their activity," says Dr Nathalie Juge f...
(Date:11/24/2009)..., BATON ROUGE Antarctica has long held secrets...and until recently, there has been very little inf... beneath miles of ice for millions of years. Now, ...uding LSU have been funded to the tune of $10 mil...r NSF, to get to the bottom of things literally. ...
(Date:11/23/2009)..., Washington, D.C. The community-associated stra... bacteria resistant to most common antibioticspose...n and is making its way into hospitals, according ...ctious Diseases . , The new threat is easily pi...lic places and has increased the overall burden of...
Breaking Biology News(10 mins):A sticky solution for identifying effective probiotics 2LSU gets to the bottom of things -- in Antarctica 2New study finds MRSA on the rise in hospital outpatients 2Cantel Medical Corp To Hold Conference Call To Discuss Fourth Quarter and Fiscal 2009 Results 5196 1Cantel Medical Corp To Hold Conference Call To Discuss Fourth Quarter and Fiscal 2009 Results 5196 2BioCryst Clarifies Government Declaration Regarding Peramivir 5192 1BioCryst Clarifies Government Declaration Regarding Peramivir 5192 2BioCryst Clarifies Government Declaration Regarding Peramivir 5192 3Case Western Reserve University discovers Merkel cell originates from skin not the neural crest 10243 1Case Western Reserve University discovers Merkel cell originates from skin not the neural crest 10243 2
...HOUSTON, July 29, 2008 Two Fortune 500 oil compan...lege of Engineering at the University of Houston. ...gy Corp. and Marathon Oil Corp., will provide supp...ngineering, which is expected to be approved by th...all. , "Marathon,s and Devon,s commendable and co...
...A University of Central Florida researcher may hav...ase that wiped out a third of Europe,s population ...erceive as a terrorist threat today. , UCF Profe...accine that early research shows is highly effecti...stitutes of Health and USDA funded research appear...
...In vertebrates with separate sexes, sex determinat...t (TSD). TSD is very common in reptiles, where the...arly development irreversibly determines whether a... males and females in a population is the sex rati...ion viability. , A number of previous studies hav...
Other Biology News:Energy industry leaders commit $1.6M to UH petroleum program 2Energy industry leaders commit $1.6M to UH petroleum program 3UCF professor develops vaccine to protect against black plague bioterror attack 2UCF professor develops vaccine to protect against black plague bioterror attack 3Fish with temperature-dependent sex determination face global warming 2
Mouse Anti-Human beta IG-H3 Monoclonal Antibody, Unconjugated, Clone 348506 from R&D Systems
Goat Anti-Human Siglec-9 Polyclonal Antibody, Biotin Conjugated from R&D Systems
Caspase Inhibitor Ac-DEVD-CHO, Unconjugated from Promega
Mouse Anti-Human RELT / TNFRSF19L Monoclonal Antibody, Unconjugated, Clone 238104 from R&D Systems
Biology Products: